摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-<6'-deoxy-2',3',5'-tris-O-(p-nitrobenzoyl)-α-L-talofuranosyl>hypoxanthine | 86527-17-5

中文名称
——
中文别名
——
英文名称
7-<6'-deoxy-2',3',5'-tris-O-(p-nitrobenzoyl)-α-L-talofuranosyl>hypoxanthine
英文别名
[(2R,3R,4R,5R)-4-(4-nitrobenzoyl)oxy-2-[(1S)-1-(4-nitrobenzoyl)oxyethyl]-5-(6-oxo-1H-purin-7-yl)oxolan-3-yl] 4-nitrobenzoate
7-<6'-deoxy-2',3',5'-tris-O-(p-nitrobenzoyl)-α-L-talofuranosyl>hypoxanthine化学式
CAS
86527-17-5
化学式
C32H23N7O14
mdl
——
分子量
729.573
InChiKey
UFILGKHSQWMCTG-VXPINWSASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    53
  • 可旋转键数:
    11
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    285
  • 氢给体数:
    1
  • 氢受体数:
    16

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-<6'-deoxy-2',3',5'-tris-O-(p-nitrobenzoyl)-α-L-talofuranosyl>hypoxanthine 作用下, 反应 48.0h, 以63%的产率得到7-(6'-deoxy-α-L-talofuranosyl)hypoxanthine
    参考文献:
    名称:
    Synthesis and antitumor activity of 7- and 9-(6'-deoxy-.alpha.-L-talofuranosyl)-hypoxanthine and 9-(6'-deoxy-.alpha.-L-talofuranosyl)-6-thiopurine
    摘要:
    Reaction of 6-deoxy-2,3,5-tris-O-(p-nitrobenzoyl)-L-talofuranosyl bromide (1) with the trimethylsilyl derivative of hypoxanthine, followed by removal of blocking groups, afforded 9- (6) and 7-(6'-deoxy-alpha-L-talofuranosyl)hypoxanthine (7). A study of the published optical rotations and circular dichroic (CD) spectra of pentofuranosylpurines and of (6'-deoxy-beta-D-allo- and -alpha-L-talofuranosyl)purines prepared here suggests that the sign of rotation and the sign of the longer wavelength Cotton effect is determined solely by the configuration of C-1' and its position of attachment to the purine ring. For C-1' R nucleosides, the sign is negative for N-9-linked purine nucleosides and positive for the N-7-linked isomers, and vice versa for C-1'S purine nucleosides. Reaction of 1 with the trimethylsilyl derivative of 6-chloropurine afforded 4, which upon treatment with thiourea and deblocking yielded 9-(6'-deoxy-alpha-L-talofuranosyl)-6-thiopurine (8). Unlike the previously prepared 7-(6'-deoxy-beta-D-allofuranosyl) hypoxanthine which strongly inhibited purine nucleoside phosphorylase, compounds 6-8 did not inhibit this enzyme. Compound 8 significantly inhibited the growth of L1210 tumor cells in vitro and in vivo.
    DOI:
    10.1021/jm00364a032
  • 作为产物:
    描述:
    6-deoxy-2,3,5-tris-O-(p-nitrobenzoyl)-α-L-talofuranosyl bromide9-三甲硅基-6-[(三甲硅基)氧]基-9H-嘌呤四氯化锡 作用下, 以 二氯甲烷 为溶剂, 以20%的产率得到7-<6'-deoxy-2',3',5'-tris-O-(p-nitrobenzoyl)-α-L-talofuranosyl>hypoxanthine
    参考文献:
    名称:
    Synthesis and antitumor activity of 7- and 9-(6'-deoxy-.alpha.-L-talofuranosyl)-hypoxanthine and 9-(6'-deoxy-.alpha.-L-talofuranosyl)-6-thiopurine
    摘要:
    Reaction of 6-deoxy-2,3,5-tris-O-(p-nitrobenzoyl)-L-talofuranosyl bromide (1) with the trimethylsilyl derivative of hypoxanthine, followed by removal of blocking groups, afforded 9- (6) and 7-(6'-deoxy-alpha-L-talofuranosyl)hypoxanthine (7). A study of the published optical rotations and circular dichroic (CD) spectra of pentofuranosylpurines and of (6'-deoxy-beta-D-allo- and -alpha-L-talofuranosyl)purines prepared here suggests that the sign of rotation and the sign of the longer wavelength Cotton effect is determined solely by the configuration of C-1' and its position of attachment to the purine ring. For C-1' R nucleosides, the sign is negative for N-9-linked purine nucleosides and positive for the N-7-linked isomers, and vice versa for C-1'S purine nucleosides. Reaction of 1 with the trimethylsilyl derivative of 6-chloropurine afforded 4, which upon treatment with thiourea and deblocking yielded 9-(6'-deoxy-alpha-L-talofuranosyl)-6-thiopurine (8). Unlike the previously prepared 7-(6'-deoxy-beta-D-allofuranosyl) hypoxanthine which strongly inhibited purine nucleoside phosphorylase, compounds 6-8 did not inhibit this enzyme. Compound 8 significantly inhibited the growth of L1210 tumor cells in vitro and in vivo.
    DOI:
    10.1021/jm00364a032
点击查看最新优质反应信息

同类化合物

马来酸恩替卡韦 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 阿巴卡韦 铁(2+)乙二酸酯-丁烷-1-胺(1:1:2) 贝伐西尼 苯甲酸,3-(2-氨基-2-氰基乙酰基)-,乙基酯 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 腺苷-3',5'-环硫代磷酸酯 腺苷-2',3'-环单硫代磷酸酯,盐内/RP-同质异能素钠 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质27 拉米夫定杂质1 拉米夫定单磷酸铵盐 拉米夫定二磷酸酯铵盐 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦杂质SSS 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物